The acquired business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications. The agreement is subject to customary closing conditions, including regulatory review.
The newly acquired business will be integrated into Honeywell's Fine Chemicals business, which has supplied high-quality research chemicals and specialty organic and inorganic compounds to the chemical and pharmaceutical industries for more than 100 years. Honeywell Fine Chemicals is a part of the Honeywell Performance Materials and Technologies business group, a global leader in developing advanced materials, process technologies and automation solutions.
The McDermott team comprised lawyers from the Firm’s corporate, IP, regulatory, tax, trial and employment practices based in Düsseldorf, Frankfurt, Munich, Dallas and Washington, including partners: Dr. Nikolaus von Jacobs, Carsten Böhm, Jason D. Krieser, Dr. Paul Melot de Beauregard, Sabine Konrad, Dr. Roland Hartmannsberger, Dr. Holger Weiß and Dr. Kian Tauser.
About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.